NO20065627L - Orale produkter - Google Patents

Orale produkter

Info

Publication number
NO20065627L
NO20065627L NO20065627A NO20065627A NO20065627L NO 20065627 L NO20065627 L NO 20065627L NO 20065627 A NO20065627 A NO 20065627A NO 20065627 A NO20065627 A NO 20065627A NO 20065627 L NO20065627 L NO 20065627L
Authority
NO
Norway
Prior art keywords
active material
content
oral products
mouthfeel
vitamin
Prior art date
Application number
NO20065627A
Other languages
English (en)
Norwegian (no)
Inventor
Tara Schaneville
Henry Knoop
Original Assignee
Biotec Films Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biotec Films Llc filed Critical Biotec Films Llc
Publication of NO20065627L publication Critical patent/NO20065627L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007—Drug-containing films, membranes or sheets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20065627A 2004-05-17 2006-12-08 Orale produkter NO20065627L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US57194904P 2004-05-17 2004-05-17
PCT/US2005/017287 WO2005115110A2 (en) 2004-05-17 2005-05-17 Oral products

Publications (1)

Publication Number Publication Date
NO20065627L true NO20065627L (no) 2006-12-08

Family

ID=35451333

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20065627A NO20065627L (no) 2004-05-17 2006-12-08 Orale produkter

Country Status (8)

Country Link
US (1) US20080057112A1 (zh)
EP (1) EP1746973A2 (zh)
JP (1) JP2007538088A (zh)
KR (1) KR20070037438A (zh)
CN (1) CN1997351A (zh)
AU (1) AU2005247421A1 (zh)
NO (1) NO20065627L (zh)
WO (1) WO2005115110A2 (zh)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9668505B2 (en) 2013-02-18 2017-06-06 Acme Specialty Products, Llc Taste masking compositions and edible forms thereof for masking the taste of foods
AU2016207821A1 (en) * 2015-01-14 2017-07-13 Pf Consumer Healthcare 1 Llc Oral delivery product
CN112472593B (zh) * 2020-11-24 2022-06-10 牡丹江医学院 一种加入甜味剂掩盖苦味的口腔溃疡药膜加工设备

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL109539A0 (en) * 1994-05-03 1994-08-26 Yissum Res Dev Co Substained-release pharmaceutical system for the delivery of antioxidants
US5736178A (en) * 1995-05-02 1998-04-07 Opta Food Ingredients, Inc. Colloidal dispersions of gluten, method of making and use therefor
US6552024B1 (en) * 1999-01-21 2003-04-22 Lavipharm Laboratories Inc. Compositions and methods for mucosal delivery
US20040096569A1 (en) * 2002-11-15 2004-05-20 Barkalow David G. Edible film products and methods of making same

Also Published As

Publication number Publication date
US20080057112A1 (en) 2008-03-06
KR20070037438A (ko) 2007-04-04
JP2007538088A (ja) 2007-12-27
WO2005115110A3 (en) 2006-05-04
WO2005115110A2 (en) 2005-12-08
EP1746973A2 (en) 2007-01-31
CN1997351A (zh) 2007-07-11
AU2005247421A1 (en) 2005-12-08

Similar Documents

Publication Publication Date Title
IT1282353B1 (it) Composizione farmaceutica, in particolare liquida, per sommanistrazione orale di ondansetron e metodi per la sua produzione
WO2004071529A3 (en) Uses of anti-insulin-like growth factor i receptor antibodies
DE60121301D1 (de) Flibanserin zur Behandlung extrapyramidaler Bewegungsstörungen
NO20063429L (no) Brusende oral opiat doseringsform
WO2007119098A3 (en) Use of an nmda receptor antagonist the treatment of tinnitus induced by cochlear excitotoxicity
NO20064521L (no) Framgangsmate og blanding for behandling av rhinitt
NO20063430L (no) Generelt lineaer, brusende oral fentanyl doseringsform, og metoder for administrering
NO20071354L (no) anvendelse av samme Butylftalid selvemulsifiserene medikamentavgivelsessystem, samt fremgangsmater for fremstilling og anvendelse av samme.
WO2005048935A3 (en) Methods of modulating immunity
NO20060977L (no) Mitokinon-derivater anvendt som mitokondrielle malsokende antioksidanter
SG155046A1 (en) Process for modifying drug crystal formation
NO20050664L (no) 2,4 substituerte indoler og anvendelse derav som 5-HT6 modulatorer
DE60326859D1 (de) Arzneimittelverabreichung
MX2022005285A (es) Producto oral y metodo de fabricacion.
DE50005529D1 (de) Orale darreichungsformen zur verabreichung einer fixen kombination von tramadol und diclofenac
NO20073830L (no) Medikamenter for behandling eller forebygging av fibrotiske sykdommer
CY1113133T1 (el) Πολυβιταμινουχο σιροπιο για παιδια ή νεαρους ενηλικες
WO2005018605A3 (en) Novel formulation of ropinirole
BRPI0417938A (pt) formulações de proteìnas hidrofóbicas em uma composição imunogênica que possui tolerabilidade aperfeiçoada
ATE411981T1 (de) Tetrahydrocarbazolderivate und deren pharmazeutische verwendung
NO20065627L (no) Orale produkter
WO2006115918A3 (en) Vla-4 antagonists
NO20071160L (no) Anvendelse av en selektiv ostrogenreseptormodulator for fremstilling av et farmasoytisk preparat for anvendelse i en fremgangsmate for behandling eller forebygging av androgenmangel
BR0314540A (pt) Métodos para o tratamento de neurodegeneração
ATE499093T1 (de) Zusammensetzung auf citicolin-basis in kombination mit vitaminen zur prävention und behandlung von augenerkrankungen